Advertisement
News
Advertisement

Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview

Thu, 04/28/2011 - 3:36am
Bio-Medicine.Org

NEW YORK, April 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview

http://www.reportlinker.com/p0460810/Pharmaceutical-Key-Trends-2011---Prescription-Pharmaceutical-Sales-Overview.html

Introduction

Prescription pharmaceutical sales in the world's major markets (US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Russia, China and India) totaled $555bn in 2009, having grown by 6.3% during 2008–09, and at a compound annual growth rate (CAGR) of 5.6% between 2005 and 2009.

Features and benefits

* Examines the prescription pharmaceutical sales growth trends across the various different therapy areas

* Assesses the leading prescription pharmaceutical brands across the each of the 12 major pharma markets

* Profiles the leading multinational and domestic pharma companies operating in each of the 12 major pharma markets

* Analyzes the forecast sales according to lifecycle stage of drug, molecule type, source of drug, geographical market, therapy area and formulation

Highlights

The US prescription pharmaceutical market generated half (50.3%) of the sales of the 12 markets analyzed, with $279bn in 2009, with sales having grown by 5.0% (CAGR, 2005–09) and 5.5% (2008–09). However, future sales growth will be shaped by three key events: the US economic downturn, healthcare reform and the patent cliff.

Pharma is set to loose approximately $108bn in sales due to the patent cl

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading